LifeStance Health Group Inc (NASDAQ: LFST) stock jumped 0.82% on Friday to $6.17 against a previous-day closing price of $6.12. With 0.64 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.84 million shares. The 52-week range on LFST shows that it touched its highest point at $9.59 and its lowest point at $4.22 during that stretch. It currently has a 1-year price target of $8.00. Beta for the stock currently stands at 1.08.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of LFST was up-trending over the past week, with a rise of 9.98%, but this was up by 11.57% over a month. Three-month performance dropped to -20.59% while six-month performance fell -26.20%. The stock gained 10.57% in the past year, while it has gained 24.90% so far this year. A look at the trailing 12-month EPS for LFST yields -0.51 with Next year EPS estimates of -0.28. For the next quarter, that number is -0.07. This implies an EPS growth rate of 26.46% for this year and 37.23% for next year.
Float and Shares Shorts:
At present, 375.96 million LFST shares are outstanding with a float of 71.19 million shares on hand for trading. On Oct 30, 2023, short shares totaled 13.98 million, which was 3.69% higher than short shares on Sep 28, 2023. In addition to Mr. Kenneth Alan Burdick as the firm’s CEO & Chairman, Mr. Danish J. Qureshi serves as its President & COO.
Through their ownership of 81.96% of LFST’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 8.15% of LFST, in contrast to 64.80% held by mutual funds. Shares owned by individuals account for 12.80%. As the largest shareholder in LFST with 6.59% of the stake, Fidelity Management & Research Co holds 24,916,864 shares worth 24,916,864. A second-largest stockholder of LFST, The Vanguard Group, Inc., holds 7,316,745 shares, controlling over 1.94% of the firm’s shares. BlackRock Fund Advisors is the third largest shareholder in LFST, holding 6,295,912 shares or 1.67% stake. With a 1.69% stake in LFST, the Fidelity Select Medical Technolog is the largest stakeholder. A total of 6,400,000 shares are owned by the mutual fund manager. The Fidelity Select Port. – Health Ca, which owns about 1.59% of LFST stock, is the second-largest Mutual Fund holder. It holds 6,000,000 shares valued at 34.98 million. Fidelity Advisor Health Care Fund holds 1.06% of the stake in LFST, owning 4,000,000 shares worth 23.32 million.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for LFST since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With LFST analysts setting a high price target of $10.00 and a low target of $6.00, the average target price over the next 12 months is $8.00. Based on these targets, LFST could surge 62.07% to reach the target high and fall by -2.76% to reach the target low. Reaching the average price target will result in a growth of 29.66% from current levels.
Summary of Insider Activity:
Insiders traded LFST stock several times over the past three months with 0 Buys and 4 Sells. In these transactions, 0 shares were bought while 169,018 shares were sold. The number of buy transactions has increased to 14 while that of sell transactions has risen to 28 over the past year. The total number of shares bought during that period was 3,858,981 while 1,227,835 shares were sold.